Concepedia

Kirstin Thelen

KT

Statistics

Publications

24

Citations

1.7K

H-Index

20

Active since

2009

Affiliations

Bayer (Germany)(Current)

Sheba Medical Center

Goethe University Frankfurt

Royal Children's Hospital

Murdoch Children's Research Institute

Kirstin Thelen is an author at Bayer (Germany) specializing in pharmacology, pharmacy, and pharmacokinetics.

Publications per year

2009–2024

24

Publications

24

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

Christoph Male, Anthonie W.A. Lensing, Joseph S. Palumbo et al. · The Lancet Haematology · 2019 · 315 citations · Full text

, , +13

Cytochrome P450-mediated metabolism in the human gut wall

Kirstin Thelen, Jennifer Dressman · Journal of Pharmacy and Pharmacology · 2009 · 265 citations · Full text

, , +17

Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, Part 1: Oral solutions

Kirstin Thelen, Katrin Coboeken, Stefan Willmann et al. · Journal of Pharmaceutical Sciences · 2011 · 139 citations · Full text

, , +17

Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals

Jan‐Frederik Schlender, Michaela Meyer, Kirstin Thelen et al. · Clinical Pharmacokinetics · 2016 · 107 citations · Full text

, , +17

Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein‐Jr phase 3 dose‐exposure‐response evaluation

Guy Young, Anthonie W.A. Lensing, Paul Monagle et al. · Journal of Thrombosis and Haemostasis · 2020 · 85 citations · Full text

, , +14

1–5 of 24